The state of New Mexico urged a judge to hold Walgreens Boots Alliance Inc responsible for fueling the opioid crisis in the state.
Dan Alberstone, a lawyer for New Mexico, told Judge Francis Matthew in the 1st Judicial Circuit of New Mexico in Santa Fe, that the opioid crisis existing in New Mexico was a foreseeable consequence of Walgreens' conduct."
Alberstone accused the company of failing to "maintain effective controls" against the diversion of opioids onto the black market, saying it dispensed suspicious prescriptions without adequate due diligence or documentation.
Steven Derringer, the lawyer arguing for Walgreens, insisted that the opioid crisis was caused by excessive prescriptions and smaller, "mom and pop" pharmacies with lax controls. He added that the state had not offered any evidence that Walgreens dispensed any prescriptions without "legitimate medical purpose."
When the non-jury trial began six weeks ago, it also included claims against Walmart Inc and Kroger Co, but those companies settled with the state last month.


GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges
South Korea’s KOSPI Jumps Over 5% as Samsung, SK Hynix Rally on Micron Earnings Boost
Trump Requests $11 Billion More in Farm Aid as Rising Costs Pressure U.S. Farmers
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test
China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion
Gold Prices Fall Below $4,000 as Strong Dollar, Fed Rate Hike Bets Weigh on Bullion
US Judge Seeks Explanation for DOJ’s Decision to Drop Gautam Adani Bribery Case
US Dollar Slips After PCE Inflation Data Eases Fed Rate Hike Expectations
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy
U.S. Supreme Court Allows Alabama’s Republican-Backed Congressional Map for 2026 Elections
SpaceX Eyes Starlink Mobile Phone Service to Challenge Verizon, AT&T, and T-Mobile
Johns Hopkins University Lays Off 110 Employees as Federal Research Funding Declines
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Asian Stocks Sink as Apple Price Hikes Spark AI Valuation Fears, South Korea and Japan Lead Selloff
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million 



